(BLND) Blend Labs - Ratings and Ratios
Exchange: NYSE • Country: United States • Currency: USD • Type: Common Stock • ISIN: US09352U1088
BLND: Cloud-Based, Software, Mortgage, Loans, Credit, Insurance, Settlement
Blend Labs Inc. (NYSE:BLND) is a fintech company that offers a cloud-based software platform designed for financial services firms in the U.S. The company operates through two main segments: the Blend Platform and Title365. The Blend Platform provides a suite of tools that enable digital-first consumer experiences across various financial products, including mortgages, home equity loans, vehicle loans, personal loans, credit cards, and deposit accounts. It also offers mortgage-related products that facilitate the homeownership journey, such as income verification, homeowners insurance, and realty services.
The platform is built with several key components: verification tools to automate tasks like income and identity checks; decisioning components that apply predefined business rules to reduce manual intervention; workflow intelligence to manage data collection and automate loan origination processes; and marketplace components that allow consumers to shop for relevant financial products during the application process. This end-to-end platform is designed to streamline and simplify the consumer experience while reducing costs and improving efficiency for financial institutions.
Through its subsidiary, Title365, the company provides title search and insurance services, escrow, and other closing and settlement services. These offerings are critical for the mortgage origination process and complement the Blend Platform by providing a more comprehensive solution for lenders. The company serves a wide range of clients, including banks, credit unions, fintech companies, and non-bank mortgage lenders.
Blend Labs was founded in 2012 and is headquartered in San Francisco, California. The company has a market capitalization of approximately $959.74 million. Key financial metrics include a forward P/E ratio of 112.36, a price-to-book ratio of 2.00, and a price-to-sales ratio of 6.12. These metrics provide insight into the companys valuation and growth potential, which are important considerations for investors and fund managers evaluating its position in the fintech landscape.
Additional Sources for BLND Stock
Tweets: X Stocktwits
Fund Manager Positions: Dataroma Stockcircle
BLND Stock Overview
Market Cap in USD | 922m |
Sector | Technology |
Industry | Software - Application |
GiC Sub-Industry | Application Software |
IPO / Inception | 2021-07-16 |
BLND Stock Ratings
Growth 5y | -32.6% |
Fundamental | -2.42% |
Dividend | 0.0% |
Rel. Strength Industry | 10.4 |
Analysts | 4.14/5 |
Fair Price Momentum | 2.85 USD |
Fair Price DCF | - |
BLND Dividends
No Dividends PaidBLND Growth Ratios
Growth Correlation 3m | -67.2% |
Growth Correlation 12m | 69.4% |
Growth Correlation 5y | -29.6% |
CAGR 5y | -38.17% |
CAGR/Max DD 5y | -0.39 |
Sharpe Ratio 12m | -1.38 |
Alpha | -2.05 |
Beta | 3.11 |
Volatility | 96.75% |
Current Volume | 5028.5k |
Average Volume 20d | 4380.2k |
As of March 18, 2025, the stock is trading at USD 3.58 with a total of 5,028,476 shares traded.
Over the past week, the price has changed by +12.23%, over one month by -10.28%, over three months by -28.97% and over the past year by +15.86%.
Neither. Based on ValueRay Fundamental Analyses, Blend Labs is currently (March 2025) neither a good nor a bad stock to buy. It has a ValueRay Fundamental Rating of -2.42 and therefor a neutral outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of BLND as of March 2025 is 2.85. This means that BLND is currently overvalued and has a potential downside of -20.39%.
Blend Labs has received a consensus analysts rating of 4.14. Therefor, it is recommend to buy BLND.
- Strong Buy: 3
- Buy: 2
- Hold: 2
- Sell: 0
- Strong Sell: 0
According to ValueRays Forecast Model, BLND Blend Labs will be worth about 3.4 in March 2026. The stock is currently trading at 3.58. This means that the stock has a potential downside of -4.47%.
Issuer | Forecast | Upside |
---|---|---|
Wallstreet Target Price | 5.1 | 43.6% |
Analysts Target Price | 5.5 | 52.2% |
ValueRay Target Price | 3.4 | -4.5% |